High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
2.88M
-94.32%
-0.090
-43.75%
2.90M
-93.74%
-0.095
-750.68%
2.20M
-95.64%
-0.235
+193.75%
Estimates Revision
The market is revising Downward the revenue expectations for FibroGen, Inc. (FGEN) for FY2025, with the revenue forecasts being adjusted by -41.83% over the past three months. During the same period, the stock price has changed by -47.69%.
Revenue Estimates for FY2025
Revise Downward
-41.83%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+85.53%
In Past 3 Month
Stock Price
Go Down
-47.69%
In Past 3 Month
2 Analyst Rating
0Wall Street analysts forecast FGEN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FGEN is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
0Current: 0.306
Low
10.00
Averages
10.00
High
10.00
0Current: 0.306
Low
10.00
Averages
10.00
High
10.00
HC Wainwright & Co.
Joseph Pantginis
Strong Buy
Reiterates
$10
2025-05-13
New
Reason
HC Wainwright & Co.
Joseph Pantginis
Price Target
$10
2025-05-13
New
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Joseph Pantginis
Strong Buy
Reiterates
$10
2025-03-18
Reason
HC Wainwright & Co.
Joseph Pantginis
Price Target
$10
2025-03-18
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Joseph Pantginis
Strong Buy
Reiterates
$10
2025-02-20
Reason
HC Wainwright & Co.
Joseph Pantginis
Price Target
$10
2025-02-20
Reiterates
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for FibroGen Inc (FGEN.O) is -0.47, compared to its 5-year average forward P/E of -9.92. For a more detailed relative valuation and DCF analysis to assess FibroGen Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-9.92
Current PE
-0.47
Overvalued PE
4.04
Undervalued PE
-23.88
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-10.19
Current EV/EBITDA
-1.72
Overvalued EV/EBITDA
12.67
Undervalued EV/EBITDA
-33.04
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
5.81
Current PS
3.06
Overvalued PS
10.54
Undervalued PS
1.09
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
Trading Trends
Insider
Insiders areBuying! The selling amount has increased 501.54% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areBuying! The selling amount has increased 501.54% over the last month.
Sold
Bought
FGEN News & Events
Events Timeline
(ET)
2025-03-28
07:12:55
FibroGen announces publication of results from Phase 1 study of FG-3246
2025-03-17 (ET)
2025-03-17
16:10:51
FibroGen reports Q4 EPS 18c, consensus (20c)
2025-02-20 (ET)
2025-02-20
06:46:52
FibroGen selling FibroGen China to AstraZeneca for $160M
Sign Up For More Events
Sign Up For More Events
News
Preview
8.5
05-13SeekingAlphaFibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipeline
Preview
9.5
05-13NASDAQ.COMFibroGen Inc. Q1 Earnings Summary
Preview
3.0
05-10SeekingAlphaFibroGen Q1 2025 Earnings Preview
Sign Up For More News
People Also Watch
FAQ
What is FibroGen Inc (FGEN) stock price today?
What is FibroGen Inc (FGEN)'s business?
What is the price predicton of FGEN Stock?
What is FibroGen Inc (FGEN)'s revenue for the last quarter?
What is FibroGen Inc (FGEN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for FibroGen Inc (FGEN)'s fundamentals?
How many employees does FibroGen Inc (FGEN). have?